Literature DB >> 22410041

Right gastroepiploic artery is the first alternative inflow source for hepatic arterial reconstruction in living donor liver transplantation.

C-S Ahn1, S Hwang, D-B Moon, G-W Song, T-Y Ha, G-C Park, J-M Namgoong, S-Y Yoon, S-W Jung, D-H Jung, K-H Kim, Y-H Park, H-W Park, H-J Lee, C-S Park, S-G Lee.   

Abstract

BACKGROUND: Sufficient arterial flow after living donor liver transplantation (LDLT) is closely related to graft survival and prevention of postoperative complications. However, some unfavorable hepatic arterial conditions in recipients preclude reconstruction, requiring alternative stumps. We have used the right gastroepiploic artery (RGEA) as a first alternative for hepatic inflow.
METHODS: From January 2006 to December 2008, we performed 754 LDLTs including 28 cases of RGEA among hepatic arterial anastomoses. The arterial anastomosis was performed by an single surgeon under 859 a microscope using an end-to-end interrupted suture technique. RGEA was mobilized over 15 cm from the greater curvature of stomach and greater omentum.
RESULTS: The indications for RGEA use included severe hepatic arterial injury from previous transarterial chemoembolization (n=14), need for additional arterial flow in dual-grafts LDLT (n=13), poor blood flow from the recipient hepatic artery (n=3), and arterial injury during hilar dissection (n=3). The mean diameter of the isolated RGEA was 2.0±0.2 mm (range: 1.0-2.5). Most hepatic arterial anastomoses were performed with a significant size discrepancy of more than twofold. All reconstructed hepatic arterial flowes showed good; no complication was identified during the mean follow-up period of 56 months to date.
CONCLUSIONS: Using RGEA as an alternative arterial inflow is a simple, reliable procedure for situations of inadequate recipient hepatic or multiple graft arteries. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22410041     DOI: 10.1016/j.transproceed.2012.01.057

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  First jejunal artery, an alternative graft for right hepatic artery reconstruction.

Authors:  Bibek Aryal; Teruo Komokata; Jun Kadono; Hiroyuki Motodaka; Tetsuya Ueno; Akira Furoi; Yutaka Imoto
Journal:  World J Hepatol       Date:  2015-04-08

2.  Hepatic artery resection and reconstruction using the right gastroepiploic artery during pancreaticoduodenectomy in advanced pancreatic cancer.

Authors:  Yoshitaro Shindo; Yukio Tokumitsu; Satoshi Matsukuma; Hiroto Matsui; Masao Nakajima; Nobuaki Suzuki; Shigeru Takeda; Yoshinobu Hoshii; Hiroaki Nagano
Journal:  Langenbecks Arch Surg       Date:  2021-04-13       Impact factor: 3.445

3.  Hepatic artery reconstruction using interposition of autologous saphenous vein conduit for living donor liver transplantation: a case report.

Authors:  Deok-Bog Moon; Shin Hwang; Dong-Hwan Jung; Chul-Soo Ahn; Gil-Chun Park; Tae-Yong Ha; Gi-Won Song; Young-In Yoon; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2021-05-14

4.  Salvage aorto-hepatic jump graft for hepatic artery thrombosis following living donor liver transplantation: a case report with 10-year follow-up.

Authors:  Jin Uk Choi; Shin Hwang; Chul-Soo Ahn; Deok-Bog Moon; Gil-Chun Park
Journal:  Korean J Transplant       Date:  2021-12-31

5.  Salvage dual graft living donor liver transplantation after major hepatectomy.

Authors:  Joo Dong Kim; Dong Lak Choi; Young Seok Han
Journal:  Ann Surg Treat Res       Date:  2014-07-29       Impact factor: 1.859

6.  Right gastroepiploic artery as an alternative for arterial reconstruction in living donor liver transplantation.

Authors:  Klaus Steinbrück; Reinaldo Fernandes; Marcelo Enne; Rafael Vasconcelos; Giuliano Bento; Gustavo Stoduto; Thomas Auel; Lúcio Filgueiras Pacheco-Moreira
Journal:  Case Reports Hepatol       Date:  2014-11-16

7.  Overcoming Hepatic Artery Thrombosis After Living Donor Liver Transplantations: An Experience from Asan Medical Center.

Authors:  Gil-Chun Park; Deok-Bog Moon; Sang-Hyun Kang; Chul-Soo Ahn; Shin Hwang; Ki-Hun Kim; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Yong-In Yoon; Sung-Gyu Lee
Journal:  Ann Transplant       Date:  2019-11-01       Impact factor: 1.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.